New biomarkers to predict the evolution of in situ breast cancers - Wikidata - wikimedia - TriplyDB

New biomarkers to predict the evolution of in situ breast cancers

New biomarkers to predict the evolution of in situ breast cancers

http://www.wikidata.org/entity/Q34162165

about

Transglutaminase is a tumor cell and cancer stem cell survival factor Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?Silencing of HJURP induces dysregulation of cell cycle and ROS metabolism in bladder cancer cells via PPARγ-SIRT1 feedback loop.Transcriptomic response of breast cancer cells to anacardic acid.

P2860

Q26799862-3EFF6D39-890F-4105-A277-895172310AF2 Q37214284-5F9BF796-EBE3-4B0E-9EE6-4C6E0ACC30E2 Q38962165-2F677E1E-6B2A-4369-948B-36604FC85C80 Q41441045-E449F766-F408-405A-84E4-43A002690575 Q55061507-0566553B-4311-4202-8314-52A860EBD7A3

P2860

New biomarkers to predict the evolution of in situ breast cancers

http://www.wikidata.org/entity/Q34162165

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

New biomarkers to predict the evolution of in situ breast cancers

@ast

New biomarkers to predict the evolution of in situ breast cancers

@en

New biomarkers to predict the evolution of in situ breast cancers

@nl

type

label

New biomarkers to predict the evolution of in situ breast cancers

@ast

New biomarkers to predict the evolution of in situ breast cancers

@en

New biomarkers to predict the evolution of in situ breast cancers

@nl

prefLabel

New biomarkers to predict the evolution of in situ breast cancers

@ast

New biomarkers to predict the evolution of in situ breast cancers

@en

New biomarkers to predict the evolution of in situ breast cancers

@nl

P1433

Q34162165-E03CD84A-A4CD-4246-97EE-0816CBB11673

P1476

Q34162165-490568D0-31B8-492D-B7A3-332152C40E20

P2093

Q34162165-013826FC-2FCF-48C2-83AF-F9CA7EE07EF5

Q34162165-25587E3F-547C-4EEE-99F4-7647DB39E4F4

Q34162165-25A5C2A4-2B01-490C-BB54-A56B3BEF78EC

Q34162165-265C942A-55CC-4066-9490-FD602B5D8461

Q34162165-475AD6E0-FF9B-4B70-ADA8-706657D62C8B

Q34162165-4A83B3B6-3CF7-47DE-B942-F6A9323E3D77

Q34162165-4E3161AD-2364-4247-AD7A-93D18760732F

Q34162165-B59B6872-4B7F-43DD-94EF-C4AEFD5DC6F1

Q34162165-B7EC5F6A-3448-4A1A-81BE-AA30F704F567

Q34162165-C585CFF4-BD90-4048-8BE0-F00585BD34AE

P2860

Q34162165-0CBC5F03-E34D-4BCA-8045-016FE6229647

Q34162165-101FF385-A51B-4AC3-B0F8-0D191BC4354F

Q34162165-309B61A9-1014-4A72-9F12-482AEF7F6260

Q34162165-334D33C6-AA8B-4766-AB54-895D7CB99F9E

Q34162165-3D1C401F-E06B-4EBB-A25D-D9378C656682

Q34162165-47E2B88F-D7EA-463F-B582-C0069BB3DC4E

Q34162165-643CBE2A-18A4-47A9-B55D-D078A80A49CE

Q34162165-701A13E6-216C-4C4D-8A30-9BDC21A0590F

Q34162165-9A6D2812-8F83-46F8-952D-33BE59698F88

Q34162165-A6AB537A-983A-4092-B668-9965651C8AF1

P304

Q34162165-ABF15230-97F2-4A8C-805E-291AAF3581F3

P31

Q34162165-8E3B14E4-6667-46C7-982F-860715BC5F57

P356

Q34162165-88B68422-19C0-483A-9299-601603E5D751

P407

Q34162165-B6EDAC42-73BA-40C9-903E-DED0B7412496

P478

Q34162165-932F588C-F485-43F5-89B9-BB7A3DFE2E5E

P50

Q34162165-625175AE-C105-45EC-9FDD-8A974CD9C720

Q34162165-9152FFDA-79DA-4E79-9816-21A8CED599E8

Q34162165-A8F234AA-B949-4180-AE1B-D9A1CD4880B4

P577

Q34162165-9921362C-24C6-442C-AB95-81EEB1F0FD27

P5875

Q34162165-6CFD80A4-0044-4309-A453-C4A2C4C26D59

P698

Q34162165-EE4F2618-E9A9-4D7C-B3A9-F204CB322F3A

P921

Q34162165-B6EF9B57-2CC8-4BA2-8921-64CDFDA9D3BD

P932

Q34162165-ACCE5669-EAE2-41BB-8ECE-7B52B324321D

P356

P1433

BioMed Research International

P1476

New biomarkers to predict the evolution of in situ breast cancers

@en

P2093

A Curcio

http://www.w3.org/2001/XMLSchema#string

A Rocca

http://www.w3.org/2001/XMLSchema#string

C Rengucci

http://www.w3.org/2001/XMLSchema#string

D Amadori

http://www.w3.org/2001/XMLSchema#string

F Buggi

http://www.w3.org/2001/XMLSchema#string

L Serra

http://www.w3.org/2001/XMLSchema#string

M Puccetti

http://www.w3.org/2001/XMLSchema#string

R Maltoni

http://www.w3.org/2001/XMLSchema#string

R Silvestrini

http://www.w3.org/2001/XMLSchema#string

S Folli

http://www.w3.org/2001/XMLSchema#string

P2860

The nuclear factor kappa B inhibitor parthenolide restores ICI 182,780 (Faslodex; fulvestrant)-induced apoptosis in antiestrogen-resistant breast cancer cells.

Tissue transglutaminase as a central mediator in inflammation-induced progression of breast cancer

Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function

The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer.

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

The management of ductal carcinoma in situ of the breast.

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers

Prognostic factors in breast cancer: current and new predictors of metastasis.

Molecular profiling of breast cancer: clinical implications

Ductal carcinoma in situ, complexities and challenges.

P304

159765

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2014/159765

http://www.w3.org/2001/XMLSchema#string

P407

P478

2014

http://www.w3.org/2001/XMLSchema#string

P50

Emanuela Scarpi

Sara Bravaccini

Maria Maddalena Tumedei

P577

2014-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265971034

http://www.w3.org/2001/XMLSchema#string

P698

25243117

http://www.w3.org/2001/XMLSchema#string

P921

P932

4160633

http://www.w3.org/2001/XMLSchema#string